nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—GRIN2C—schizophrenia	0.213	0.278	CbGaD
Amantadine—GRIN2D—schizophrenia	0.198	0.258	CbGaD
Amantadine—GRIN1—schizophrenia	0.134	0.174	CbGaD
Amantadine—GRIN2A—schizophrenia	0.0966	0.126	CbGaD
Amantadine—GRIN2B—schizophrenia	0.0822	0.107	CbGaD
Amantadine—DRD2—schizophrenia	0.0289	0.0377	CbGaD
Amantadine—ABCB1—schizophrenia	0.0146	0.019	CbGaD
Amantadine—GRIN1—telencephalic ventricle—schizophrenia	0.00455	0.0693	CbGeAlD
Amantadine—GRIN2B—telencephalic ventricle—schizophrenia	0.00434	0.0661	CbGeAlD
Amantadine—DDC—telencephalic ventricle—schizophrenia	0.00355	0.054	CbGeAlD
Amantadine—DDC—pineal body—schizophrenia	0.00308	0.0468	CbGeAlD
Amantadine—DDC—blood plasma—schizophrenia	0.00169	0.0257	CbGeAlD
Amantadine—DRD2—telencephalic ventricle—schizophrenia	0.00154	0.0234	CbGeAlD
Amantadine—GRIN2C—forebrain—schizophrenia	0.00144	0.0218	CbGeAlD
Amantadine—GRIN2D—forebrain—schizophrenia	0.00133	0.0203	CbGeAlD
Amantadine—GRIN2C—telencephalon—schizophrenia	0.00132	0.0201	CbGeAlD
Amantadine—GRIN3A—forebrain—schizophrenia	0.00125	0.0191	CbGeAlD
Amantadine—GRIN2D—telencephalon—schizophrenia	0.00123	0.0187	CbGeAlD
Amantadine—GRIN1—forebrain—schizophrenia	0.00119	0.0181	CbGeAlD
Amantadine—GRIN3A—telencephalon—schizophrenia	0.00115	0.0175	CbGeAlD
Amantadine—GRIN2B—forebrain—schizophrenia	0.00113	0.0173	CbGeAlD
Amantadine—GRIN1—telencephalon—schizophrenia	0.00109	0.0166	CbGeAlD
Amantadine—GRIN2B—telencephalon—schizophrenia	0.00104	0.0159	CbGeAlD
Amantadine—GRIN2A—forebrain—schizophrenia	0.000992	0.0151	CbGeAlD
Amantadine—DDC—forebrain—schizophrenia	0.000927	0.0141	CbGeAlD
Amantadine—GRIN2A—telencephalon—schizophrenia	0.000912	0.0139	CbGeAlD
Amantadine—MAOB—blood plasma—schizophrenia	0.00087	0.0132	CbGeAlD
Amantadine—DDC—telencephalon—schizophrenia	0.000852	0.013	CbGeAlD
Amantadine—GRIN1—midbrain—schizophrenia	0.000785	0.0119	CbGeAlD
Amantadine—GRIN2C—nervous system—schizophrenia	0.000779	0.0119	CbGeAlD
Amantadine—GRIN2C—central nervous system—schizophrenia	0.00075	0.0114	CbGeAlD
Amantadine—GRIN2C—cerebellum—schizophrenia	0.000733	0.0112	CbGeAlD
Amantadine—GRIN2D—nervous system—schizophrenia	0.000724	0.011	CbGeAlD
Amantadine—GRIN2D—central nervous system—schizophrenia	0.000697	0.0106	CbGeAlD
Amantadine—GRIN1—endocrine gland—schizophrenia	0.00069	0.0105	CbGeAlD
Amantadine—GRIN2D—cerebellum—schizophrenia	0.000682	0.0104	CbGeAlD
Amantadine—GRIN3A—nervous system—schizophrenia	0.000681	0.0104	CbGeAlD
Amantadine—GRIN2B—endocrine gland—schizophrenia	0.000658	0.01	CbGeAlD
Amantadine—GRIN3A—central nervous system—schizophrenia	0.000656	0.00997	CbGeAlD
Amantadine—GRIN2A—midbrain—schizophrenia	0.000655	0.00996	CbGeAlD
Amantadine—GRIN1—nervous system—schizophrenia	0.000646	0.00982	CbGeAlD
Amantadine—GRIN1—central nervous system—schizophrenia	0.000622	0.00945	CbGeAlD
Amantadine—GRIN2B—nervous system—schizophrenia	0.000616	0.00937	CbGeAlD
Amantadine—DDC—midbrain—schizophrenia	0.000612	0.00931	CbGeAlD
Amantadine—GRIN1—cerebellum—schizophrenia	0.000608	0.00924	CbGeAlD
Amantadine—GRIN2C—brain—schizophrenia	0.000596	0.00906	CbGeAlD
Amantadine—GRIN2B—central nervous system—schizophrenia	0.000593	0.00902	CbGeAlD
Amantadine—GRIN2B—cerebellum—schizophrenia	0.00058	0.00882	CbGeAlD
Amantadine—GRIN2A—endocrine gland—schizophrenia	0.000575	0.00875	CbGeAlD
Amantadine—GRIN2D—brain—schizophrenia	0.000554	0.00842	CbGeAlD
Amantadine—SLC22A1—forebrain—schizophrenia	0.000539	0.0082	CbGeAlD
Amantadine—GRIN2A—nervous system—schizophrenia	0.000538	0.00819	CbGeAlD
Amantadine—DDC—endocrine gland—schizophrenia	0.000537	0.00817	CbGeAlD
Amantadine—GRIN3A—brain—schizophrenia	0.000521	0.00792	CbGeAlD
Amantadine—GRIN2A—central nervous system—schizophrenia	0.000518	0.00788	CbGeAlD
Amantadine—GRIN2A—cerebellum—schizophrenia	0.000507	0.00771	CbGeAlD
Amantadine—DDC—nervous system—schizophrenia	0.000503	0.00765	CbGeAlD
Amantadine—SLC22A1—telencephalon—schizophrenia	0.000496	0.00754	CbGeAlD
Amantadine—GRIN1—brain—schizophrenia	0.000493	0.00751	CbGeAlD
Amantadine—DDC—central nervous system—schizophrenia	0.000484	0.00737	CbGeAlD
Amantadine—MAOB—forebrain—schizophrenia	0.000477	0.00725	CbGeAlD
Amantadine—GRIN2B—brain—schizophrenia	0.000471	0.00716	CbGeAlD
Amantadine—SIGMAR1—telencephalon—schizophrenia	0.000458	0.00696	CbGeAlD
Amantadine—MAOB—telencephalon—schizophrenia	0.000438	0.00667	CbGeAlD
Amantadine—GRIN2A—brain—schizophrenia	0.000411	0.00626	CbGeAlD
Amantadine—DRD2—forebrain—schizophrenia	0.000402	0.00612	CbGeAlD
Amantadine—DDC—brain—schizophrenia	0.000384	0.00585	CbGeAlD
Amantadine—DRD2—telencephalon—schizophrenia	0.00037	0.00563	CbGeAlD
Amantadine—SLC22A1—blood—schizophrenia	0.00036	0.00548	CbGeAlD
Amantadine—SIGMAR1—blood—schizophrenia	0.000333	0.00506	CbGeAlD
Amantadine—SIGMAR1—midbrain—schizophrenia	0.000329	0.005	CbGeAlD
Amantadine—MAOB—blood—schizophrenia	0.000319	0.00485	CbGeAlD
Amantadine—ABCB1—blood plasma—schizophrenia	0.000317	0.00483	CbGeAlD
Amantadine—MAOB—midbrain—schizophrenia	0.000315	0.00479	CbGeAlD
Amantadine—SLC22A1—endocrine gland—schizophrenia	0.000313	0.00475	CbGeAlD
Amantadine—SLC22A1—nervous system—schizophrenia	0.000293	0.00445	CbGeAlD
Amantadine—SLC22A1—central nervous system—schizophrenia	0.000282	0.00428	CbGeAlD
Amantadine—MAOB—endocrine gland—schizophrenia	0.000276	0.00421	CbGeAlD
Amantadine—DRD2—midbrain—schizophrenia	0.000266	0.00404	CbGeAlD
Amantadine—MAOB—nervous system—schizophrenia	0.000259	0.00394	CbGeAlD
Amantadine—SIGMAR1—cerebellum—schizophrenia	0.000254	0.00387	CbGeAlD
Amantadine—MAOB—central nervous system—schizophrenia	0.000249	0.00379	CbGeAlD
Amantadine—MAOB—cerebellum—schizophrenia	0.000243	0.0037	CbGeAlD
Amantadine—DRD2—endocrine gland—schizophrenia	0.000233	0.00355	CbGeAlD
Amantadine—SLC22A1—brain—schizophrenia	0.000224	0.0034	CbGeAlD
Amantadine—DRD2—nervous system—schizophrenia	0.000218	0.00332	CbGeAlD
Amantadine—DRD2—central nervous system—schizophrenia	0.00021	0.0032	CbGeAlD
Amantadine—SIGMAR1—brain—schizophrenia	0.000207	0.00314	CbGeAlD
Amantadine—DRD2—cerebellum—schizophrenia	0.000205	0.00313	CbGeAlD
Amantadine—MAOB—brain—schizophrenia	0.000198	0.00301	CbGeAlD
Amantadine—ABCB1—forebrain—schizophrenia	0.000174	0.00264	CbGeAlD
Amantadine—DRD2—brain—schizophrenia	0.000167	0.00254	CbGeAlD
Amantadine—ABCB1—telencephalon—schizophrenia	0.00016	0.00243	CbGeAlD
Amantadine—ABCB1—gonad—schizophrenia	0.000133	0.00203	CbGeAlD
Amantadine—ABCB1—blood—schizophrenia	0.000116	0.00177	CbGeAlD
Amantadine—ABCB1—midbrain—schizophrenia	0.000115	0.00175	CbGeAlD
Amantadine—ABCB1—endocrine gland—schizophrenia	0.000101	0.00153	CbGeAlD
Amantadine—ABCB1—nervous system—schizophrenia	9.44e-05	0.00144	CbGeAlD
Amantadine—ABCB1—central nervous system—schizophrenia	9.09e-05	0.00138	CbGeAlD
Amantadine—ABCB1—cerebellum—schizophrenia	8.88e-05	0.00135	CbGeAlD
Amantadine—ABCB1—brain—schizophrenia	7.21e-05	0.0011	CbGeAlD
Amantadine—DRD2—Signaling by GPCR—HTR6—schizophrenia	7.71e-06	4.6e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	7.7e-06	4.6e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR7—schizophrenia	7.7e-06	4.6e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3C2A—schizophrenia	7.59e-06	4.53e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CHRM1—schizophrenia	7.5e-06	4.48e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PRODH—schizophrenia	7.48e-06	4.47e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC17A7—schizophrenia	7.48e-06	4.47e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIP4K2A—schizophrenia	7.4e-06	4.42e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	7.35e-06	4.39e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NDUFV2—schizophrenia	7.33e-06	4.38e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—CYP1A2—schizophrenia	7.31e-06	4.37e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—IL3RA—schizophrenia	7.31e-06	4.36e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—TH—schizophrenia	7.21e-06	4.3e-05	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	7.08e-06	4.23e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GRM5—schizophrenia	6.97e-06	4.16e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIP4K2A—schizophrenia	6.89e-06	4.12e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—schizophrenia	6.87e-06	4.1e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DGKI—schizophrenia	6.83e-06	4.08e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CHRM1—schizophrenia	6.81e-06	4.07e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP2D6—schizophrenia	6.81e-06	4.06e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SNAP25—schizophrenia	6.81e-06	4.06e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP26B1—schizophrenia	6.69e-06	3.99e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL3RA—schizophrenia	6.64e-06	3.96e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—GABRB2—schizophrenia	6.63e-06	3.96e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	6.41e-06	3.82e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CCK—schizophrenia	6.38e-06	3.81e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GRM5—schizophrenia	6.33e-06	3.78e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPP1R1B—schizophrenia	6.24e-06	3.73e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP26B1—schizophrenia	6.23e-06	3.72e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PDE4B—schizophrenia	6.22e-06	3.71e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CYP1A2—schizophrenia	6.16e-06	3.67e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—COMT—schizophrenia	6.13e-06	3.66e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CCKAR—schizophrenia	6.11e-06	3.65e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MPC2—schizophrenia	6.1e-06	3.64e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTP1—schizophrenia	6.1e-06	3.64e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—MAOA—schizophrenia	6.09e-06	3.63e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—TH—schizophrenia	6.07e-06	3.62e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TPH1—schizophrenia	5.96e-06	3.56e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GCLM—schizophrenia	5.96e-06	3.56e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—ADORA2A—schizophrenia	5.93e-06	3.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FZD3—schizophrenia	5.8e-06	3.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCK—schizophrenia	5.79e-06	3.46e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	5.78e-06	3.45e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—ABCB1—schizophrenia	5.77e-06	3.45e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC18A2—schizophrenia	5.73e-06	3.42e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—EP300—schizophrenia	5.68e-06	3.39e-05	CbGpPWpGaD
Amantadine—ABCB1—Allograft Rejection—TNF—schizophrenia	5.67e-06	3.39e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLCH2—schizophrenia	5.67e-06	3.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PDE4B—schizophrenia	5.64e-06	3.37e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PRKD1—schizophrenia	5.61e-06	3.35e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PLA2G4A—schizophrenia	5.61e-06	3.35e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—GSTM1—schizophrenia	5.61e-06	3.35e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TPH1—schizophrenia	5.56e-06	3.32e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GCLM—schizophrenia	5.56e-06	3.32e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCKAR—schizophrenia	5.55e-06	3.31e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—NPY—schizophrenia	5.54e-06	3.31e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—EP300—schizophrenia	5.53e-06	3.3e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ABCB1—schizophrenia	5.51e-06	3.29e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GRM2—schizophrenia	5.46e-06	3.26e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TAAR6—schizophrenia	5.46e-06	3.26e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FES—schizophrenia	5.46e-06	3.26e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPP3CC—schizophrenia	5.46e-06	3.26e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—HTR2A—schizophrenia	5.39e-06	3.22e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—ADORA2A—schizophrenia	5.38e-06	3.21e-05	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—EP300—schizophrenia	5.35e-06	3.19e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR1B—schizophrenia	5.34e-06	3.19e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—OXT—schizophrenia	5.34e-06	3.19e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NDST3—schizophrenia	5.33e-06	3.18e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC6A1—schizophrenia	5.27e-06	3.15e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PRKD1—schizophrenia	5.22e-06	3.12e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—COMT—schizophrenia	5.16e-06	3.08e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR1A—schizophrenia	5.14e-06	3.07e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTP1—schizophrenia	5.13e-06	3.06e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ABCB1—schizophrenia	5.13e-06	3.06e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MAOA—schizophrenia	5.12e-06	3.06e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—NPS—schizophrenia	5.07e-06	3.02e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ACSL6—schizophrenia	5.05e-06	3.02e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC27A5—schizophrenia	5.05e-06	3.02e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NGEF—schizophrenia	5.05e-06	3.01e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—NPY—schizophrenia	5.03e-06	3e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD1—schizophrenia	4.97e-06	2.97e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2C—schizophrenia	4.97e-06	2.97e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—MTHFR—schizophrenia	4.95e-06	2.96e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NTS—schizophrenia	4.94e-06	2.95e-05	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—AKT1—schizophrenia	4.88e-06	2.91e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ABCB1—schizophrenia	4.86e-06	2.9e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—OXT—schizophrenia	4.85e-06	2.9e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR1B—schizophrenia	4.85e-06	2.9e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DAO—schizophrenia	4.82e-06	2.88e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD3—schizophrenia	4.81e-06	2.87e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PLA2G4A—schizophrenia	4.72e-06	2.82e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GSTM1—schizophrenia	4.72e-06	2.82e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ATP2A2—schizophrenia	4.7e-06	2.8e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GAPDH—schizophrenia	4.68e-06	2.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR1A—schizophrenia	4.67e-06	2.79e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—DRD4—schizophrenia	4.67e-06	2.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RGS4—schizophrenia	4.64e-06	2.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RTN4—schizophrenia	4.64e-06	2.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GRM3—schizophrenia	4.64e-06	2.77e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CLOCK—schizophrenia	4.64e-06	2.77e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PNP—schizophrenia	4.62e-06	2.76e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—APOE—schizophrenia	4.61e-06	2.75e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—TNF—schizophrenia	4.61e-06	2.75e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—NPS—schizophrenia	4.6e-06	2.75e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—APOA1—schizophrenia	4.56e-06	2.72e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR6—schizophrenia	4.56e-06	2.72e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TPH2—schizophrenia	4.52e-06	2.7e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CACNB2—schizophrenia	4.52e-06	2.7e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD1—schizophrenia	4.51e-06	2.69e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2C—schizophrenia	4.51e-06	2.69e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TNF—schizophrenia	4.49e-06	2.68e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CNR1—schizophrenia	4.46e-06	2.66e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—DPYD—schizophrenia	4.44e-06	2.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAG—schizophrenia	4.4e-06	2.63e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD3—schizophrenia	4.37e-06	2.61e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GAPDH—schizophrenia	4.36e-06	2.6e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR7—schizophrenia	4.35e-06	2.6e-05	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—APOA1—schizophrenia	4.35e-06	2.6e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CLOCK—schizophrenia	4.32e-06	2.58e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NDUFV2—schizophrenia	4.3e-06	2.57e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—DRD4—schizophrenia	4.24e-06	2.53e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CACNB2—schizophrenia	4.21e-06	2.51e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TPH2—schizophrenia	4.21e-06	2.51e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MTHFR—schizophrenia	4.17e-06	2.49e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—DPYD—schizophrenia	4.14e-06	2.47e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CACNA1C—schizophrenia	4.13e-06	2.47e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—APOA1—schizophrenia	4.05e-06	2.42e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CNR1—schizophrenia	4.05e-06	2.42e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIP4K2A—schizophrenia	4.04e-06	2.41e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3C2A—schizophrenia	4.03e-06	2.4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CHRM1—schizophrenia	4.02e-06	2.4e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR7—schizophrenia	3.95e-06	2.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL3RA—schizophrenia	3.92e-06	2.34e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APOE—schizophrenia	3.88e-06	2.32e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CACNA1C—schizophrenia	3.85e-06	2.3e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—APOA1—schizophrenia	3.84e-06	2.29e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NRG3—schizophrenia	3.83e-06	2.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TLE1—schizophrenia	3.83e-06	2.28e-05	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—schizophrenia	3.83e-06	2.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GFAP—schizophrenia	3.78e-06	2.26e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	3.75e-06	2.24e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3C2A—schizophrenia	3.75e-06	2.24e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GRM5—schizophrenia	3.74e-06	2.23e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP26B1—schizophrenia	3.65e-06	2.18e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TLE3—schizophrenia	3.62e-06	2.16e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP2D6—schizophrenia	3.61e-06	2.16e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SNAP25—schizophrenia	3.61e-06	2.16e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	3.45e-06	2.06e-05	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—AKT1—schizophrenia	3.43e-06	2.05e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCK—schizophrenia	3.42e-06	2.04e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP2D6—schizophrenia	3.37e-06	2.01e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SNAP25—schizophrenia	3.37e-06	2.01e-05	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—AKT1—schizophrenia	3.34e-06	2e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PDE4B—schizophrenia	3.33e-06	1.99e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCKAR—schizophrenia	3.28e-06	1.96e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CYP1A2—schizophrenia	3.27e-06	1.95e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TPH1—schizophrenia	3.26e-06	1.94e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCLM—schizophrenia	3.26e-06	1.94e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—TH—schizophrenia	3.22e-06	1.92e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADORA2A—schizophrenia	3.18e-06	1.9e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PLA2G4A—schizophrenia	3.13e-06	1.87e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PRKD1—schizophrenia	3.06e-06	1.83e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGA—schizophrenia	3.05e-06	1.82e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2A—schizophrenia	3.05e-06	1.82e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CYP1A2—schizophrenia	3.04e-06	1.82e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—TH—schizophrenia	3e-06	1.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NPY—schizophrenia	2.97e-06	1.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOTCH4—schizophrenia	2.97e-06	1.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ATP2A2—schizophrenia	2.97e-06	1.77e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR1B—schizophrenia	2.87e-06	1.71e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—OXT—schizophrenia	2.87e-06	1.71e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	2.8e-06	1.67e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—schizophrenia	2.77e-06	1.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR1A—schizophrenia	2.76e-06	1.65e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—COMT—schizophrenia	2.74e-06	1.63e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTP1—schizophrenia	2.72e-06	1.63e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MAOA—schizophrenia	2.72e-06	1.62e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NPS—schizophrenia	2.72e-06	1.62e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD1—schizophrenia	2.67e-06	1.59e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2C—schizophrenia	2.67e-06	1.59e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—EP300—schizophrenia	2.63e-06	1.57e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NTRK2—schizophrenia	2.59e-06	1.55e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD3—schizophrenia	2.58e-06	1.54e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ABCB1—schizophrenia	2.58e-06	1.54e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GAPDH—schizophrenia	2.56e-06	1.53e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—COMT—schizophrenia	2.55e-06	1.52e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTP1—schizophrenia	2.54e-06	1.52e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MAOA—schizophrenia	2.53e-06	1.51e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CLOCK—schizophrenia	2.53e-06	1.51e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DRD4—schizophrenia	2.51e-06	1.5e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PLA2G4A—schizophrenia	2.5e-06	1.49e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTM1—schizophrenia	2.5e-06	1.49e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TPH2—schizophrenia	2.47e-06	1.47e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CACNB2—schizophrenia	2.47e-06	1.47e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.47e-06	1.47e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DPYD—schizophrenia	2.43e-06	1.45e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ABCB1—schizophrenia	2.4e-06	1.43e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CNR1—schizophrenia	2.39e-06	1.43e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—APOA1—schizophrenia	2.38e-06	1.42e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR7—schizophrenia	2.33e-06	1.39e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PLA2G4A—schizophrenia	2.33e-06	1.39e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTM1—schizophrenia	2.33e-06	1.39e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CACNA1C—schizophrenia	2.26e-06	1.35e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—schizophrenia	2.21e-06	1.32e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—EP300—schizophrenia	2.21e-06	1.32e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRL—schizophrenia	2.2e-06	1.32e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3C2A—schizophrenia	2.2e-06	1.31e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	2.08e-06	1.24e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—schizophrenia	2.06e-06	1.23e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOE—schizophrenia	2.06e-06	1.23e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—S100B—schizophrenia	2.05e-06	1.23e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOA1—schizophrenia	2.04e-06	1.22e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SNAP25—schizophrenia	1.97e-06	1.18e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2D6—schizophrenia	1.97e-06	1.18e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB4—schizophrenia	1.97e-06	1.17e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOE—schizophrenia	1.92e-06	1.15e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOA1—schizophrenia	1.9e-06	1.13e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLA2G4A—schizophrenia	1.85e-06	1.1e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NRG1—schizophrenia	1.81e-06	1.08e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MEF2C—schizophrenia	1.8e-06	1.07e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP1A2—schizophrenia	1.78e-06	1.07e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TH—schizophrenia	1.76e-06	1.05e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—YWHAZ—schizophrenia	1.74e-06	1.04e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB3—schizophrenia	1.7e-06	1.01e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—schizophrenia	1.64e-06	9.76e-06	CbGpPWpGaD
Amantadine—DDC—Metabolism—AKT1—schizophrenia	1.59e-06	9.48e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOE—schizophrenia	1.52e-06	9.07e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOA1—schizophrenia	1.5e-06	8.97e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—COMT—schizophrenia	1.5e-06	8.93e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTP1—schizophrenia	1.49e-06	8.88e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MAOA—schizophrenia	1.48e-06	8.86e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ESR1—schizophrenia	1.45e-06	8.66e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLA2G4A—schizophrenia	1.37e-06	8.16e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTM1—schizophrenia	1.37e-06	8.16e-06	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKT1—schizophrenia	1.34e-06	7.98e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GSK3B—schizophrenia	1.32e-06	7.86e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—schizophrenia	1.21e-06	7.22e-06	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—EP300—schizophrenia	1.17e-06	7.01e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOE—schizophrenia	1.13e-06	6.72e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOA1—schizophrenia	1.11e-06	6.64e-06	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—EP300—schizophrenia	1.09e-06	6.53e-06	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT1—schizophrenia	9.76e-07	5.83e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT1—schizophrenia	8.86e-07	5.29e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EP300—schizophrenia	8.66e-07	5.17e-06	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKT1—schizophrenia	7.09e-07	4.23e-06	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKT1—schizophrenia	6.61e-07	3.95e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—EP300—schizophrenia	6.41e-07	3.83e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—schizophrenia	6.2e-07	3.7e-06	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT1—schizophrenia	5.23e-07	3.13e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKT1—schizophrenia	3.88e-07	2.31e-06	CbGpPWpGaD
